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Background: Identifying those patients who have a higher chance to be cured with fewer side effects by particle
beam therapy than by state-of-the-art photon therapy is essential to guarantee a fair and sufficient access to
specialized radiotherapy. The individualized identification requires initiatives by particle as well as non-particle
radiotherapy centers to form networks, to establish procedures for the decision process, and to implement means
for the remote exchange of relevant patient information. In this work, we want to contribute a practical concept
that addresses these requirements.
Methods: We proposed a concept for individualized patient allocation to photon or particle beam therapy at a
non-particle radiotherapy institution that bases on remote treatment plan comparison. We translated this concept
into the web-based software tool ReCompare (REmote COMparison of PARticlE and photon treatment plans).
Results: We substantiated the feasibility of the proposed concept by demonstrating remote exchange of
treatment plans between radiotherapy institutions and the direct comparison of photon and particle treatment
plans in photon treatment planning systems. ReCompare worked with several tested standard treatment
planning systems, ensured patient data protection, and integrated in the clinical workflow.
Conclusions: Our concept supports non-particle radiotherapy institutions with the patient-specific treatment
decision on the optimal irradiation modality by providing expertise from a particle therapy center. The software
tool ReCompare may help to improve and standardize this personalized treatment decision. It will be available
from our website when proton therapy is operational at our facility.
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A promising strategy to improve the treatment of cancer
is to apply patient-specific, technologically optimized
radiotherapy that may also include particle irradiation
such as proton or carbon ion beam therapy. While the
number of particle therapy centers worldwide increases
steadily [1] the relative number of cancer patients who
are treated with this technique—and may therefore* Correspondence: armin.luehr@OncoRay.de
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unless otherwise stated.benefit from its potential advantages—remains small
compared to those patients treated with conventional
photon therapy. To guarantee an equal and sufficient
access to optimal radiotherapy, it is essential to identify
those patients that have a higher chance to be cured
with fewer side effects by particle therapy than by
state-of-the-art photon therapy. Thus, patients need to
be individually allocated to exactly that irradiation type
that offers them the best chance for cure.
Currently, it is still subject of investigation on which
criteria an attending physician should base a final decision
regarding the treatment modality for an individual patient.
One practical solution is a direct comparison of patient-
specific dose distributions to discriminate between treat-d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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of available state-of-the-art tumor control probability and
normal tissue complication probability models [4,5]. For
example, in the Netherlands a two-step approach of dose
comparison and complication prediction is compulsory
for reimbursing model-based indications [2].
Most cancer patients will initially be referred to a non-
particle radiotherapy institution, which only has access
to conventional irradiation modalities and therefore has
only limited experience with particle therapy. The identi-
fication of patients that benefit most from radiotherapy
with particles requires initiatives by particle as well as
non-particle radiotherapy centers to form networks, to
establish a procedure for the decision process, and to
implement means for the remote exchange of relevant
patient information.
In response to these requirements our objective was
twofold: we wanted to
1. propose a concept for individualized patient
allocation to photon or particle radiotherapy, based
on remote treatment plan exchange and comparison;
2. develop a software tool that translates this concept
into practical use.
A purposeful software solution that supports the iden-
tification and allocation of patients should meet several
specifications, namely, realize remote transmission of
patient data between radiotherapy institutions; require
minimal time and financial effort from users; comply
with standard treatment planning systems; integrate into
routine clinical workflow; and consider safety measures
and IT requirements for the use in clinical environments
including patient data protection issues.
Methods
Concept of individualized patient allocation to
particle therapy
Currently, the available clinical and radiobiological data
for particle irradiation are for most cases insufficient to
exclusively base a treatment decision on them [6,7]. In-
stead, patient allocation that relies on patient-specific
treatment plan comparison appears to be more robust
[8] and is therefore the basis for our concept, which is
explained in what follows.
The (initial) treatment decision for most patients will
be made at a non-particle radiotherapy institution that
lacks the competence of particle therapy planning. Never-
theless, radiation oncologists at non-particle radiotherapy
institutions are clearly qualified to identify treatment
plans that do not meet the criteria of the prescription
(e.g., do not deliver the required dose to the tumor at
acceptable levels of expected complications). For such
cases, experienced personnel at the particle therapy centergenerate a particle therapy plan on the basis of the patient
data accumulated at the non-particle radiotherapy institu-
tion, but with a different planning target volume (PTV)
that considers the uncertainties at the particle therapy
center. After receiving this particle treatment plan the
non-particle radiotherapy institution performs a com-
parison with its own state-of-the-art photon plan and
may finally come up with an individualized treatment
decision whether to allocate the patient to a treatment
with either photon or particle therapy. Note, this concept
implies the important aspect of cooperation and exchange
between a non-particle radiotherapy institution and a
particle therapy center, which is an integral part of a well-
founded decision on the different treatment options.
The workflow (depicted schematically in Figure 1)
includes the preparation and transmission of patient
and treatment plan data [steps 2 to 5]. The exchange is
realized by the developed software tool ReCompare
(REmote COMparison of PARticlE and photon treatment
plans)—cf. the manuscript (Lühr et al.: Implementation of
ReCompare – remote comparison of particle and photon
treatment plans, in preparation) for implementation de-
tails. The preparation of the photon or particle treatment
plan as well as the (final) plan comparison are performed
at each institution with the same treatment planning
system that is routinely used for this purpose to integrate
the exchange process into clinical workflow. Patient data
acquired during the application of ReCompare, i.e., pairs
of pseudonymized conventional and particle therapy plans,
are available from the database. They may be subject to
later internal comparison for quality assurance as well
as serve as a valuable data basis for clinical research
regarding different irradiation modalities. The exchange,
comparison, and optional scientific analysis of patient data
require the informed consent of the patient. A document
for this purpose—containing information for patients
on the data handling—will be provided to the external
non-particle radiotherapy institutions, which considers
the applicable law and regulations, in particular the
(German) data protection law.
Structure of ReCompare
The remote treatment plan exchange software ReCompare
consists of three main components (as schematically
depicted in Figure 2): (1) a local client at (each of ) the
non-particle radiotherapy institution(s), (2) one client
at the particle therapy center, and (3) one central server
module with a database.
The communication and data transfer between clients
and the server are performed based on the Hypertext
Transfer Protocol Secure (HTTPS) [9] to ensure secure
data transmission. The server communicates via the inter-
net with clients at external non-particle radiotherapy
institutions and via a local network connection with the
Figure 1 Schematic workflow of treatment decision process based on plan comparison for photon and particle irradiation. The software
ReCompare provides functionality to exchange the plans between the photon and particle therapy centers and to store plans in a database, i.e.,
it enables steps 2 to 5 (cf. text for details). NPRI: non-particle radiotherapy institution; PTC: particle therapy center; TPS: treatment planning system.
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to other secure protocols (e.g., File Transfer Protocol over
Transport Layer Security [FTPS]) for two reasons: first,
other protocols than HTTPS are not allowed by many
institutions and second, HTTPS allows performing the
entire communication (e.g., database requests) additionally
to the data transfer through one interface. In general,
individual processing steps during the plan exchange
process are checked for consistency and the exchange
is terminated in the case that a test fails.
A complete plan data set consists of data files in
Digital Imaging and Communications in Medicine
(DICOM) format [9] containing the patient computed
tomography (CT), the radiation therapy (RT) structure
set, the RT plan, and the RT dose distribution. Before
uploading a photon plan, the files in DICOM format are
(i) tested for completeness and consistency, (ii) pseudony-
mized, while (iii) a subset of the pseudonymized patientFigure 2 Structure of the remote plan exchange software ReCompare
particle therapy centers, respectively. They connect via HTTPS with the cen
for the exchange. The two implemented languages English and German ardata (e.g., patient ID and birth date) is—after encryption
using the Advanced Encryption Standard (AES) [10]—
stored in a file. In contrast to fully anonymized data
sets, in which all patient identifying fields are replaced,
pseudonymization preserves some less identifying pa-
tient information (e.g., patient age and radiotherapy
center) that might be of relevance for the treatment
process. The pseudonymization has to preserve the
intrinsic relations between the DICOM files, i.e., re-
placing the intrinsic referencing identifiers with pseu-
donyms in a consistent way. Otherwise, a subsequent
DICOM import would fail, since the set of DICOM
files could not be recognized to belong to one treat-
ment plan. Due to the procedures in (ii) and (iii) only
the non-particle radiotherapy institution can identify
the patient and access patient-identifying data (e.g.,
name and date of birth) with their local encryption key.
The checks in (i) intend to prevent faulty operation. It consists of two different clients: one for photon and one for
tral server module, which provides a database storing the patient data
e demonstrated.
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consistency of the data (e.g., selected DICOM files do
not belong together or do not form a complete plan) as
well as the successful completion of processing steps
(e.g., pseudonymization or writing to the database).
During the initial upload process of a photon plan, the
user can provide additional metadata, such as tumor
location and fractionation scheme, which are then
available to the particle therapy center for the purpose of
treatment planning.
The final plan comparison takes place at the non-particle
radiotherapy institution where the attending physician is
responsible for the treatment decision. For this purpose
the ReCompare software writes the dose distribution of
a particle plan into a template file for a photon dose
distribution in DICOM format that can be imported
into photon treatment planning systems. Also during
the particle plan upload, the staff at the particle therapy
center may add supplementary notes regarding, e.g.,
the robustness of the particle plan, that are of relevance
for a treatment decision. After the download of the par-
ticle plan, which is based on the same CT as the photon
plan, the comparison of the dose distributions takes
place in the standard treatment planning system of the
non-particle radiotherapy institution and according to
the procedure of that institution, which may base, e.g.,
on a dose volume histogram and a slice-by-slice dose
level evaluation.
ReCompare fits seamlessly in the daily clinical workflow
by being compatible with a number of standard treatment
planning systems. These systems support planning for
photon and/or proton irradiation while compatibility
with planning systems capable of ions heavier than protons
is under development. The configuration of the client
software is kept simple and requires minimal effort by
all users. The installation of the server part has to be
performed in accordance to relevant requirements for
protecting patient data in that country. As an example,
the design of the server installation at our facility is dis-
cussed in the manuscript (Lühr et al.: Implementation
of ReCompare – remote comparison of particle and
photon treatment plans, in preparation).
Results
We developed and tested the software tool ReCompare
(REmote COMparison of PARticlE and photon treat-
ment plans), which facilitates the exchange of photon
and particle treatment plans between different radiother-
apy institutions.
The web-based approach of ReCompare allows true
remote transmissions of patient data and plans, in
principle, between any two radiotherapy centers that
have access to the internet. This includes the plan
exchange also between different countries as shown inFigure 3 for the example of a photon plan for a head
and neck cancer patient that was transmitted between
the university hospitals Aarhus, Denmark and Dresden,
Germany. The comparison of the dose volume histograms
shows that the file transfer between different treatment
planning systems (here between Eclipse and Oncentra
Masterplan) via ReCompare preserves the quantitative
dose information.
The usability of the concept and its implementation
was confirmed by clinical personnel for various body sites,
including lung, head and neck, prostate, and breast.
Clinically, these test applications showed that potentially
relevant advantages of one irradiation modality over the
other appear to be patient specific and cannot easily be
generalized. Figure 4 shows the direct comparison of a
photon with a proton treatment plan as done at a non-
particle radiotherapy institution for an esophagus cancer
patient.
ReCompare is—due to its design—easy to use and re-
quires only minimal effort by the user. The focused
functionality and the small number of buttons in the
graphical user interface of the local clients ensure easy
usability and reduce the chance of unintended faulty
operations. The latter are also prevented by automatic
consistency checks before and after individual processing
steps considering, e.g., completeness of treatment plans
and success of the upload process. It takes about 1 minute
to initiate (selecting the matching DICOM folder and
providing metadata) an upload of a photon plan to the
server. The following transfer of all files of a plan via
the internet took in our tests also approximately 1 minute
(total file size about 100 MB). The duration depends,
however, on the total file size of the plan and the speed
of the internet connection. The local client comes with
a free to use license and its setup is kept simple. The
user can choose between different languages: currently
English and German are supported.
Discussion
We proposed a concept that enables non-particle radio-
therapy institutions to actively participate in allocating
their patients to either state-of-the-art photon or particle
therapy based on a patient-specific treatment plan com-
parison for cases when the optimal photon plan fails to
fulfill the prescription criteria. Furthermore, we translated
this concept into the software tool ReCompare (REmote
COMparison of PARticlE and photon treatment plans),
which realizes web-based remote transmission of patient
data and thereby allows to compare conventional with
particle treatment plans at a non-particle radiotherapy
institution. ReCompare is easy to use, freely available,
protects patient data, and is compatible with several
standard treatment planning systems. It has therefore the
potential to seamlessly integrate into clinical work flow.
Figure 3 Remote transmission of photon treatment plan of a head and neck cancer patient. Dose volume histograms. Left: the plan was
created in Aarhus, Denmark using Eclipse. Then ReCompare pseudonymized the plan and sent it via HTTPS to Dresden, Germany. Right: after
download from the server the plan was visualized in Dresden with Oncentra Masterplan.
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is also based on other relevant factors (beyond the
comparison of dose distributions), such as age, tumor
location or radioresistance. Recommendations without
the need for plan comparison—and therefore without
ReCompare—can be given for indications where par-
ticle irradiation results in a clear advantage or disad-
vantage. Examples are diagnoses that are either accepted
indications for particle treatment (e.g., following inter-
national guidelines) or indications for which no particle
treatment is established, respectively. We expect, however,
that momentarily most cases do not belong to one of
these groups. Then, dose comparison is the only robust
method to quantify differences and potential benefits
between the treatment modalities for an individual
patient [7]. They are therefore requested by manyFigure 4 Comparison of photon (left) and proton (right) treatment pl
was performed with ReCompare. The proton plan was planned with XiO a
the displayed plan comparison.authorities before they approve coverage of treatment ex-
penses [2,11]. The Radiation Oncology Collaborative Com-
parison (ROCOCO) consortium performs multicentric in
silico trials comparing photon and particle radiotherapy on
the level of treatment plan comparison. Their results for
non-small cell lung cancer indicate that the best treatment
modality should be investigated on an individual patient
basis [8] and are therefore in line with our findings and
other current work [12]. A key element of our concept is
that the radiation oncologist at the non-particle radiotherapy
institution finally decides who to treat locally and who to
refer.
The concept of remote treatment plan comparison
includes the necessity to send patient data out of a
clinical institution and is implemented in ReCompare by
using network connections as it was done, e.g., for theans for the same esophagus cancer patient. The plan exchange
nd the photon plan with Oncentra Masterplan, which was also used for
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data protection. First, only the non-particle radiotherapy in-
stitution has access to the full patient data since pseudony-
mization and depseudonymization happen locally. Second,
all patient data are sent via a secure protocol (HTTPS)
and the data transfer process is checked for completeness.
Third, the server—being remotely accessible as well as
protected by a restrictive firewall—is implemented to
comply with data protection standards. Finally, the entire
concept depends on the informed consent of the patient
and we provide appropriate documentation and forms.
The presented findings encourage to apply the proposed
concept and the software ReCompare on a larger clinical
scale involving several radiotherapy institutions. A prac-
tical trial is currently initiated between the university hos-
pital in Dresden as a particle therapy center and a
number of non-particle radiotherapy institutions in
Europe. Furthermore, the proposed concept may also sup-
port the comparison of photon plans optimized at different
institutions (using different techniques). Presumably, a fully
established expert system that supports the treatment de-
cision by additionally including reliable state-of-the art
clinical and radiobiological data and models will supersede
the current approach [14]. Our work serves as a first step
on the way to design and implement such an approach.
We believe that the benefits of our proposed concept
are threefold. First of all, patients may benefit. Most of
them are initially referred to a non-particle radiotherapy
institution. Based on a treatment plan comparison the
patient-specific allocation to a treatment modality may
become more robust. Especially at remote institutions the
chance for a referral of a patient with a high probability to
profit from particle therapy may increase. Second, the
non-particle radiotherapy institutions clearly benefit from
the extra expertise regarding particle therapy which they
get provided in the form of treatment plans. The continu-
ous exchange should also serve as basis for the formation
of networks between institutions with and without particle
irradiation. And finally, particle therapy centers may benefit
from an improved (pre-) selection of patients on an individ-
ual basis. Being able to exclusively treat those patients that
are most profiting could maximize the efficacy of a particle
irradiation (facility) and therefore justify the reimbursement
of higher treatment expenses—usually associated with such
a specialized treatment technique—by health insurances
both in general and for individual patients.
Conclusions
Our concept may help to establish a fair and sufficient
access to specialized radiotherapy resources based on a
standardized treatment plan comparison performed at
non-particle radiotherapy institutions. The software tool
ReCompare provides a secure and simple web-based
exchange of photon and particle treatment plans. It willbe available from our website when proton therapy is
operational at our facility.
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